RT Journal Article
SR Electronic
T1 Predicting diagnostic conversion from major depressive disorder to bipolar disorder: an EHR based study from Colombia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.28.23296092
DO 10.1101/2023.09.28.23296092
A1 Service, Susan K.
A1 De La Hoz, Juan
A1 Diaz-Zuluaga, Ana M.
A1 Arias, Alejandro
A1 Pimplaskar, Aditya
A1 Luu, Chuc
A1 Mena, Laura
A1 Valencia, Johanna
A1 Ramírez, Mauricio Castaño
A1 Bearden, Carrie E.
A1 Sabbati, Chiara
A1 Reus, Victor I.
A1 López-Jaramillo, Carlos
A1 Freimer, Nelson B.
A1 Loohuis, Loes M. Olde
YR 2023
UL http://medrxiv.org/content/early/2023/10/02/2023.09.28.23296092.abstract
AB Bipolar Disorder (BD) is a severe and chronic disorder characterized by recurrent episodes of depression, mania, and/or hypomania. Most BD patients initially present with depressive symptoms, resulting in a delayed diagnosis of BD and poor clinical outcomes. This study leverages electronic health record (EHR) data from the Clínica San Juan de Dios Manizales in Colombia to identify features predictive of the transition from Major Depressive Disorder (MDD) to BD.Analyzing EHR data from 13,607 patients diagnosed with MDD over 15 years, we identified 1,610 cases of conversion to BD. Using a multivariate Cox regression model, we identified severity of the initial MDD episode, the presence of psychosis and hospitalization at first episode, family history of mood or psychotic disorders, female gender to be predictive of the conversion to BD. Additionally, we observed associations with medication classes (prescriptions of mood stabilizers, antipsychotics, and antidepressants) and clinical features (delusions, suicide attempt, suicidal ideation, use of marijuana and alcohol use/abuse) derived from natural language processing (NLP) of clinical notes. Together, these risk factors predicted BD conversion within five years of the initial MDD diagnosis, with a recall of 72% and a precision of 38%.Our study confirms many previously identified risk factors identified through registry-based studies (such as female gender and psychotic depression at the index MDD episode), and identifies novel ones (specifically, suicidal ideation and suicide attempt extracted from clinical notes). These results simultaneously demonstrate the validity of using EHR data for predicting BD conversion as well as underscore its potential for the identification of novel risk factors and improving early diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported here was supported by R00MH116115 (to LMOL), R01MH123157 (to LMOL, CLJ, and NBF) and R01MH113078 (to CEB, CLJ, and NBF)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was granted by The Institutional Review Board, Medical Institutional Review Board 3, at UCLA; the Comité de Ética del Instituto de Investigaciones Médicas, at Universidad de Antioquia; and the Comité de Bioética de Clinica San Juan de Dios, at CSJDM.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNA